Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

RIGEL PHARMACEUTICALS INC Director's Dealing 2020

Aug 21, 2020

32801_dirs_2020-08-20_901d360b-51f5-4101-ae49-42286f294a02.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2020-08-10

Reporting Person: Santos David A (EVP, Chief Commercial Officer)

More from RIGEL PHARMACEUTICALS INC

Regulatory Filings 2026
May 20
Proxy Solicitation & Information Statement 2026
Apr 3
Major Shareholding Notification 2026
Mar 27
Regulatory Filings 2026
Mar 3
Annual Report 2026
Mar 3
Director's Dealing 2026
Feb 24
Director's Dealing 2026
Feb 19
Director's Dealing 2026
Feb 19
Director's Dealing 2026
Feb 19
Director's Dealing 2026
Feb 19
View all filings →